BioPharm Business News and Perspectives

Thursday, March 12, 2009 Judge Puts Generic Evista on Hold
A US District Court has put a 10-day hold on Teva Pharmaceuticals' plan to launch a generic version of Eli Lilly's Evista (raloxifene) osteoporosis drug...

Thursday, March 05, 2009 First Nonsurgical Dupuytren's Rx Likely to Be Auxilium's Xiaflex
Auxilium Pharmaceuticals is requesting expedited approval for Xiaflex™ (clostridial collagenase for injection), a nonsurgical treatment for Dupuytren's contracture...

Thursday, February 26, 2009 Pfizer Stops Work on Esreboxetine for FM
Pfizer has stopped development of esreboxetine, which was in phase II trials for fibromyalgia...

Thursday, February 19, 2009 Raptiva^® Pulled in EU After 3rd PML Case; FDA Warns US Docs
European regulators suspended sales of the psoriasis drug Raptiva^® after a 3rd PML death, and the FDA warned US doctors of a 4th suspected case...

Monday, February 16, 2009 FDA Gives Nod to Uloric^® (febuxostat), First New Gout Treatment in 40 Years
The US FDA approved 40 mg and 80 mg doses of Takeda Pharmaceutical's febuxostat (Uloric) for the chronic management of hyperuricemia in patients with gout...

Friday, February 13, 2009 La Jolla and Biomarin Dump Riquent, Cite “Futile” Phase 3 Lupus Data
La Jolla Pharmaceutical has ended work on Riquent^® (abetimus sodium)after the first interim efficacy analysis for the ASPEN Phase 3 lupus nephritis trial...

Friday, February 06, 2009 Galderma's Vectical™ Gets FDA OK for Psoriasis
Vectical vitamin D3 ointment has been approved by the FDA for mild-to-moderate plaque psoriasis...

Tuesday, February 03, 2009 Lilly to Pursue OA Pain Indication for Cymbalta
Will OA join depression and fibromyalgia as Cymbalta indications?...

Wednesday, January 21, 2009 FDA Grounds Pfizer's Fablyn Osteoporosis Drug
Pfizer's Fablyn (lasofoxifene) is still on hold as FDA seeks more safety data...

Friday, January 16, 2009 FDA Backs Savella for Fibromyalgia
FDA has approved Cypress Bioscience's Savella for fibromyalgia pain, function, and well-being...